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Abstract: A simple, efficient, and environmentally benign method has been
developed for the exclusive formation of biologically significant 2-aryl-1-
arylmethyl-1H-benzimidazoles under the heterogeneous catalysis of Amberlite
IR-120 in aqueous media in excellent yields. The catalyst is recyclable without loss
of activity.
Keywords: Amberlite IR-120, aqueous media, chemoselective, 1,2-disubstituted
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1,2-Disubstituted benzimidazoles are endowed with an extensive range of
biological activities. They have emerged as potent nonnucleoside inhibi-
tors of HIV-1 reverse transcriptase[1a,1b] and specific inhibitors of the
NS5B polymerase of the hepatitis C virus (HCV).[1c] Appropriately
functionalized 1,2-disubstituted benzimidazoles are used as agonists
against c-butyric acid A receptor (GABAA).
[1d] Moreover, they display
potent thrombin inhibitory activity[2a] and antibacterial activity against
gram-positive bacteria.[2b]
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A number of improved methods have been developed for the synthesis
of 1,2-disubstituted benzimidazoles, which include N-alkylation of
2-substituted benzimidazole in the presence of a strong base,[3a,3b] N-
alkylation of o-nitroanilides followed by reductive cyclization,[1a,1b]
cyclocondensation of N-substituted o-aminoanilides,[2a] reductive cycliza-
tion of o-nitroanilides followed by N-alkylation in the presence of a strong
base,[1b] and condensation of N-substituted phenylenediamine with
sodium salt of a-hydroxybenzylsulphonic acid.[2b] In addition, 1,2-
disubstituted benzimidazoles can also be accessed by direct one-step
condensation of o-phenylenediamines with aldehydes under the influence
of different acid catalysts.[4] But one of the major limitations of these
methodologies is that they show poor selectivity in terms of N-1 substitu-
tion, which results in the formation of two compounds (i.e., the formation
of 2-substituted benzimidazole along with 1,2-disubstituted benzimida-
zole as a mixture[4a–c,4e]). We report the synthesis of 1,2-disubstituted
benzimidazoles by the reaction of o-phenylenediamines and aldehydes in
the presence of Amberlite IR-120 resin (Scheme 1).
At the beginning of this work, to evaluate the catalytic efficiency of
Amberlite IR-120, the reaction of o-phenylenediamine and benzaldehyde
was studied by employing 0.100 g of the catalyst in water at room tem-
perature. The resulting yield was not very good (entry 1, Table 1).
Optimization of the reaction condition was carried out next to increase
the yield of the product, employing different catalyst loadings in a wide
variety of solvents. The results are listed in Table 1. The conversion
was dramatically increased to 95% within a much shorter time by adding
0.100 g of the catalyst in an ethanol=water (2:1) mixture (entry 3). It was
found that a higher amount of the catalyst did not improve the yield at all
(entries 6 and 7), whereas the yield was substantially reduced by decreas-
ing the amount of Amberlite IR-120 in an ethanol=water (2:1) mixture
(entries 4 and 5). Methanol=water (2:1) mixture was also found to be
Scheme 1. Synthesis of 2-aryl-1-arylmethyl-1H-benzimidazoles.




































an effective reaction medium for this transformation (entry 12). Other
solvents, such as CH3CN, CHCl3, CH2Cl2, toluene, tetrohydrofuran
(THF), and dioxane (entries 13–18), rendered unfavorable results for
this reaction. Otherwise, silica gel and alumina (entries 19 and 20) as
heterogeneous catalysts also furnished high yield of products. Evidently,
the reaction conditions in entry 3 of Table 1 were found to be the most
optimal.
To test the generality of this reaction, a series of aromatic aldehydes and
o-phenylenediamines was subjected to the optimal reaction conditions.








1 Amberlite IR-120 0.100 H2O 3.00 66
2 Amberlite IR-120 0.100 EtOH 1.45 90
3 Amberlite IR-120 0.100 EtOHþH2O (2:1) 1.45 95
4 Amberlite IR-120 0.050 EtOHþH2O (2:1) 7.00 80
5 Amberlite IR-120 0.075 EtOHþH2O (2:1) 3.00 86
6 Amberlite IR-120 0.125 EtOHþH2O (2:1) 2.00 95
7 Amberlite IR-120 0.150 EtOHþH2O (2:1) 2.00 95
8 Amberlite IR-120 0.100 EtOHþH2O (1:2) 2.50 83
9 Amberlite IR-120 0.100 EtOHþH2O (1:1) 2.10 90
10 Amberlite IR-120 0.100 EtOHþH2O (3:1) 1.45 92
11 Amberlite IR-120 0.100 MeOH 6.30 84
12 Amberlite IR-120 0.100 MeOHþH2O (2:1) 7.00 85
13 Amberlite IR-120 0.100 MeCN 22.00 59
14 Amberlite IR-120 0.100 CHCl3 10.00 47
15 Amberlite IR-120 0.100 CH2Cl2 10.00 37
16 Amberlite IR-120 0.100 Toluene 10.00 51
17 Amberlite IR-120 0.100 THF 9.00 62
18 Amberlite IR-120 0.100 Dioxane 9.00 53
19 Silica gel 0.100 EtOHþH2O (2:1) 3.00 80
20 Alumina 0.100 EtOHþH2O (2:1) 3.00 81
aIsolated yield.
bStirring at 25–30 C.




































Table 2. Synthesis of 2-aryl-1-arylmethyl-1H-benzimidazoleb











































































































bStirring at 25–30 C.




































Almost all substrates could give their corresponding 1,2-disubstituted
benzimidazoles exclusively as a single product (i.e., without the formation
of 2-substituted benzimidazoles). The results are documented in Table 2.
It is noteworthy that 2,4-dichlorobenzaldehyde represents as a single
exceptional example by furnishing 2-substituted benzimidazole exclu-
sively instead of 1,2-disubstituted benzimidazole (Scheme 2).
In conclusion, the synthetic protocol described herein allows the for-
mation of biologically significant 2-aryl-1-arylmethyl-1H-benzimidazoles
exclusively under the heterogeneous catalysis of Amberlite IR-120 in
aqueous media in excellent yields.
EXPERIMENTAL
General Experimental Procedure for the Synthesis of 2-Aryl-1-
arylmethyl-1H-benzimidazoles
In a 50-ml, round-bottom flask, o-phenylenediamine (1mmol) and alde-
hyde (2mmol) were stirred in the presence of Amberlite IR-120 (0.100 g)
in an EtOH=H2 O (2:1) mixture (10ml) at room temperature for the
stipulated time. The progress of the reaction was monitored by thin-
layer-chromatography (TLC). After completion of the reaction, the
solution was filtered to remove the catalyst. The filtrate was concentrated
under reduced pressure to furnish the crude product, which was recrystal-
lized from methanol to afford the pure product. The catalyst could be
reused for fresh reactions without any loss of activity.
Characterization Data of the 2-Aryl-1-arylmethyl-1H-benzimidazoles
1-Benzyl-2-phenyl-1H-1,3-benzimidazole (1)
Mp 132 C; 1HNMR (CDCl3, 300MHz): d 5.34 (s, 2H), 7.01–7.28 (m, 8H),
7.34–7.40 (m, 3H), 7.62–7.64 (m, 2H), 7.83 (d, J¼ 8 Hz, 1H); FT-IR
Scheme 2. Synthesis of 2-(2,4-dichlorophenyl)-1H-benzimidazole.




































(KBr, cm–1): 1613.9; ESI-MS (m=z): 285.2 (Mþþ 1). Anal. calcd. for
C20H16N2: C, 84.48; H, 5.67; N, 9.85. Found: C, 84.41; H, 5.63; N, 9.89.
1-(4-Methylbenzyl)-2-(4-methylphenyl)-1H-1,3-benzimidazole (2)
Mp 128–130 C; 1H NMR (CDCl3, 300MHz): d 2.47 (s, 3H), 2.53 (s,
3H), 5.54 (s, 2H), 7.11 (d, J¼ 7.9 Hz, 2H), 7.25 (d, J¼ 7.9 Hz, 2H),
7.33–7.37 (m, 2H), 7.35 (d, J¼ 8 Hz, 2H), 7.39 (m, 1H), 7.70 (d, J¼ 8.1
Hz, 2H), 7.97 (d, J¼ 8.1 Hz, 1H); FT-IR (KBr, cm–1): 1621.7; ESI-MS
(m=z): 313.2 (Mþþ 1). Anal. calcd. for C22H20N2: C, 84.58; H, 6.45; N,
8.97. Found: C, 84.50; H, 6.41; N, 8.90.
1-(4-Methoxybenzyl)-2-(4-methoxyphenyl)-1H-1,3-benzimidazole (3)
Mp 130 C; 1H NMR (CDCl3, 300MHz): d 3.84 (s, 3H), 3.78 (s, 3H),
5.38 (s, 2H), 6.83 (d, J¼ 8.4 Hz, 2H), 6.95 (d, J¼ 8.5 Hz, 2H), 7.01 (d,
J¼ 8.01 Hz, 2H), 7.20–7.30 (m, 3H), 7.61 (d, J¼ 8.6 Hz, 2H), 7.84 (d,
J¼ 7.7 Hz, 1H); FT-IR (KBr, cm–1): 1619.3; ESI-MS (m=z): 345.3
(Mþþ 1). Anal. calcd. for C22H20N2O2 : C, 76.72; H, 5.85; N, 9.29.
Found: C, 76.77; H, 5.80; N, 9.22.
1-(4-Chlorobenzyl)-2-(4-chlorophenyl)-1H-1,3-benzimidazole (4)
Mp 135–136 C; 1H NMR (CDCl3, 300MHz): d 5.35 (s, 2H), 7.14
(d, J¼ 7.1 Hz, 2H), 7.23 (d, J¼ 8.7 Hz, 1H), 7.27–7.56 (m, 8H), 7.81
(d, J¼ 7.2 Hz, 1H); FT-IR (KBr, cm–1): 1619.8; ESI-MS (m=z): 354.2
(Mþþ 1). Anal. calcd. for C20H14 N2Cl2: C, 68.00; H, 3.99; N, 7.93.
Found: C, 68.07; H, 3.91; N, 7.98.
1-(4-Bromobenzyl)-2-(4-bromophenyl)-1H-1,3-benzimidazole (5)
Mp 157–158 C; 1HNMR (CDCl3, 300MHz): d 5.38 (s, 2H), 6.95 (d, J¼ 8.4
Hz, 2H), 7.20–7.59 (m, 9H), 7.86 (d, J¼ 7.2 Hz, 1H); FT-IR (KBr, cm–1):
1622.0; ESI-MS (m=z): 443.1 (Mþþ 1). Anal. calcd. for C20H14N2Br2: C,
54.33; H, 3.19; N, 6.34. Found: C, 54.29; H, 3.12; N, 6.40.
1-(3,4-Dimethoxybenzyl)-2-(3,4-dimethoxyphenyl)-1H-
1,3-benzimidazole (6)
Mp 171–173 C; 1H NMR (DMSO-d6, 300MHz): d 3.76 (s, 3H), 3.78
(s, 3H), 3.84 (s, 3H), 3.93 (s, 3H), 5.44 (s, 2H), 6.61–6.68 (m, 2H), 6.80




































(d, J¼ 8.2 Hz, 1H), 6.95 (d, J¼ 8.2 Hz, 1H), 7.22–7.32 (m, 4H), 7.55 (m,
1H), 7.79–7.91 (m, 1H); FT-IR (KBr, cm–1): 1613.1; ESI-MS (m=z): 405.1
(Mþþ 1). Anal. calcd. for C24H24N2O4: C, 71.27; H, 5.98; N, 6.93.
Found: C, 71.20; H, 5.93; N, 6.99.
1-(2-Chlorobenzyl)-2-(2-chlorophenyl)-1H-1,3-benzimidazole (7)
Mp 157–159 C; 1H NMR (CDCl3, 300MHz): d 5.35 (s, 2H), 6.59
(dd, J¼ 8.6 and 1.3Hz, 1H), 7.27–7.01 (m, 1H), 7.10–7.53 (m, 9H),
6.86 (d, J¼ 8.8 Hz, 1H); FT-IR (KBr, cm–1): 1615.9; ESI-MS (m=z):
354.2 (Mþþ 1). Anal. calcd. for C20H14N2Cl2: C, 68.00; H, 3.99; N,
7.93. Found: C, 68.09; H, 4.03; N, 7.98.
1-(4-Hydroxy-3-methoxybenzyl)-2-(4-hydroxy-3-methoxyphenyl)-1H-
1,3-benzimidazole (8)
Mp 184–186 C; 1H NMR (DMSO-d6, 300MHz): d 3.72 (s, 3H), 3.76
(s, 3H), 5.41 (s, 2H), 6.48 (d, J¼ 8.1 Hz, 1H), 7.76 (d, J¼ 8.0 Hz,
1H), 6.94 (d, J¼ 8.1 Hz, 1H), 7.13–7.45 (m, 5H), 7.73 (d, J¼ 8.0 Hz,
1H), 7.77–7.89 (m, 1H), 9.25 (s, 1H), 9.32 (s, 1H); FT-IR (KBr, cm1):
1623.3, 3447.2; ESI-MS (m=z): 377.2 (Mþþ 1). Anal. calcd. for




Mp 229–231 C; 1H NMR (DMSO-d6, 300MHz): d 3.82 (s, 3H), 3.90
(s, 3H), 5.35 (s, 2H), 6.77 (d, J¼ 8.1 Hz, 1H), 6.90 (d, J¼ 8.2 Hz, 1H),
7.11–7.27 (m, 5H), 7.62–7.73 (m, 3H), 8.60 (s, 1H), 8.82 (s, 1H); FT-IR
(KBr, cm–1): 1621.8, 3436.9; ESI-MS (m=z): 377.2 (Mþþ 1). Anal. calcd.
for C22H20N2O4: C, 70.20; H, 5.36; N, 7.44. Found: C, 70.24; H, 5.39; N,
7.47.
1-(2-Methoxybenzyl)-2-(2-methoxyphenyl)-1H-1,3-benzimidazole (10)
Mp 151–153 C; 1H NMR (CDCl3, 300MHz): d 3.72 (s, 3H), 3.76 (s,
3H), 5.31 (s, 2H), 6.71 (dd, J¼ 7.2 and 1.3Hz, 1H), 6.76 (m, 1H),
6.84 (d, J¼ 8.3 Hz, 1H), 6.97 (d, J¼ 8.9 Hz, 1H), 7.05–7.48 (m,
6H), 7.53 (dd, J¼ 8.6 and 2.4Hz, 1H), 7.91 (d, J¼ 8.6 Hz, 1H);
FT-IR (KBr, cm–1): 1618.6; ESI-MS (m=z): 345.3 (Mþþ 1). Anal.




































calcd. for C22H20N2O2: C, 76.72; H, 5.85; N, 9.29. Found: C, 76.79;
H, 5.82; N, 9.28.
1-(4-Hydroxybenzyl)-2-(4-hydroxyphenyl)-1H-1,3-benzimidazole (11)
Mp 222 C; 1H NMR (DMSO-d6, 300MHz): d 5.50 (s, 2H), 6.82–7.82
(m, 12H), 9.44 (s, 1H), 9.95 (s, 1H); FT-IR (KBr, cm–1): 1618.7, 3445.0;
ESI-MS (m=z): 317.1 (Mþþ 1). Anal. calcd. for C20H16N2O2: C, 75.93;
H, 5.10; N, 8.86. Found: C, 75.99; H, 5.08; N, 8.82.
1-(3-Hydroxybenzyl)-2-(3-hydroxyphenyl)-1H-1,3-benzimidazole (12)
Mp 253 C; 1H NMR (DMSO-d6, 300MHz): d 5.22 (s, 2H), 6.69–7.34
(m, 12H), 8.35 (s, 1H), 8.70 (s, 1H); FT-IR (KBr, cm–1): 1618.3, 3438.7;
ESI-MS (m=z): 317.1 (Mþþ 1). Anal. calcd. for C20H16N2O2: C, 75.93;
H, 5.10; N, 8.86. Found: C, 75.97; H, 5.15; N, 8.90.
1-(2-Furylmethyl)-2-(2-furyl)-1H-1,3-benzimidazole (13)
Mp 94–96 C; 1H NMR (DMSO-d6, 300MHz): d 5.58 (s, 2H), 6.19
(m, 1H), 6.25 (m, 1H), 6.62 (m, 1H), 7.17 (m, 1H), 7.24–7.29 (m, 3H),
7.46–7.53 (m, 1H), 7.62–7.82 (m, 2H); FT-IR (KBr, cm–1): 1622.0; ESI-
MS (m=z): 265.1 (Mþþ 1). Anal. calcd. for C16H12N2O2: C, 72.72; H,
4.58; N, 10.60. Found: C, 72.78; H, 4.52; N, 10.55.
5,6-Dimethyl-1-(4-methylbenzyl)-2-(4-methylphenyl)-
1H-benzimidazole (14)
Mp 177–178 C; 1H NMR (CDCl3, 300MHz): d 2.32 (s, 3H), 2.36 (s,
3H), 2.41 (s, 3H), 2.43 (s, 3H), 5.39 (s, 2H), 7.01–7.70 (m, 10H); FT-IR
(KBr, cm–1): 1621.3; ESI-MS (m=z): 341.4 (Mþþ 1). Anal. calcd. for
C24H24N2: C, 84.67; H, 7.11; N, 8.23. Found: C, 84.62; H, 7.18; N, 8.19.
1-(4-chlorobenzyl)-2-(4-chlorophenyl)-5,6-dimethyl-
1H-benzimidazole (15)
Mp 190–191 C; 1H NMR (CDCl3, 300MHz): d 2.34 (s, 3H), 2.37 (s, 3H),
5.42 (s, 2H), 7.04–7.81 (m, 10H); FT-IR (KBr, cm–1): 1618.8; ESI-MS




































(m=z): 382.4 (Mþþ 1). Anal. calcd. for C22H18N2Cl2: C, 69.30; H, 4.76;
N, 7.35. Found: C, 69.26; H, 4.71; N, 7.38.
2-(2,4-Dichlorophenyl)-1H-benzimidazole (Scheme 2)
Mp 227 C; 1H NMR (DMSO-d6, 300MHz): d 7.27–7.78 (m, 6H), 8.00
(d, J¼ 8.4 Hz, 1H), 12.67 (s, 1H); FT-IR (KBr, cm–1): 1655.3, 3378.0;
ESI-MS (m=z): 263.9 (Mþþ 1). Anal. calcd. for C13H8N2Cl2: C, 59.34;
H, 3.06; N, 10.65. Found: C, 59.39; H, 3.10; N, 10.60.
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